Cargando…

Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma

Detalles Bibliográficos
Autores principales: Gimotty, Phyllis A., Till, Jacob E., Udgata, Shirsa, Takenaka, Naomi, Yee, Stephanie S., LaRiviere, Michael J., O’Hara, Mark H., Reiss, Kim A., O’Dwyer, Peter, Katona, Bryson W., Herman, Daniel, Carpenter, Erica L., Zaret, Kenneth S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629808/
https://www.ncbi.nlm.nih.gov/pubmed/36322403
http://dx.doi.org/10.18632/oncotarget.28127
_version_ 1784823471163834368
author Gimotty, Phyllis A.
Till, Jacob E.
Udgata, Shirsa
Takenaka, Naomi
Yee, Stephanie S.
LaRiviere, Michael J.
O’Hara, Mark H.
Reiss, Kim A.
O’Dwyer, Peter
Katona, Bryson W.
Herman, Daniel
Carpenter, Erica L.
Zaret, Kenneth S.
author_facet Gimotty, Phyllis A.
Till, Jacob E.
Udgata, Shirsa
Takenaka, Naomi
Yee, Stephanie S.
LaRiviere, Michael J.
O’Hara, Mark H.
Reiss, Kim A.
O’Dwyer, Peter
Katona, Bryson W.
Herman, Daniel
Carpenter, Erica L.
Zaret, Kenneth S.
author_sort Gimotty, Phyllis A.
collection PubMed
description
format Online
Article
Text
id pubmed-9629808
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-96298082022-11-04 Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma Gimotty, Phyllis A. Till, Jacob E. Udgata, Shirsa Takenaka, Naomi Yee, Stephanie S. LaRiviere, Michael J. O’Hara, Mark H. Reiss, Kim A. O’Dwyer, Peter Katona, Bryson W. Herman, Daniel Carpenter, Erica L. Zaret, Kenneth S. Oncotarget Correction Impact Journals LLC 2022-11-02 /pmc/articles/PMC9629808/ /pubmed/36322403 http://dx.doi.org/10.18632/oncotarget.28127 Text en Copyright: © 2022 Gimotty et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Gimotty, Phyllis A.
Till, Jacob E.
Udgata, Shirsa
Takenaka, Naomi
Yee, Stephanie S.
LaRiviere, Michael J.
O’Hara, Mark H.
Reiss, Kim A.
O’Dwyer, Peter
Katona, Bryson W.
Herman, Daniel
Carpenter, Erica L.
Zaret, Kenneth S.
Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
title Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
title_full Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
title_fullStr Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
title_full_unstemmed Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
title_short Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
title_sort correction: thbs2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629808/
https://www.ncbi.nlm.nih.gov/pubmed/36322403
http://dx.doi.org/10.18632/oncotarget.28127
work_keys_str_mv AT gimottyphyllisa correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT tilljacobe correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT udgatashirsa correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT takenakanaomi correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT yeestephanies correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT larivieremichaelj correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT oharamarkh correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT reisskima correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT odwyerpeter correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT katonabrysonw correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT hermandaniel correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT carpentererical correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma
AT zaretkenneths correctionthbs2asaprognosticbiomarkerforpatientsdiagnosedwithmetastaticpancreaticductaladenocarcinoma